| Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma PH Thaker, LY Han, AA Kamat, JM Arevalo, R Takahashi, C Lu, ... Nature medicine 12 (8), 939-944, 2006 | 1394 | 2006 |
| Paraneoplastic thrombocytosis in ovarian cancer RL Stone, AM Nick, IA McNeish, F Balkwill, HD Han, J Bottsford-Miller, ... New England Journal of Medicine 366 (7), 610-618, 2012 | 844 | 2012 |
| Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway YG Lin, AB Kunnumakkara, A Nair, WM Merritt, LY Han, GN Armaiz-Pena, ... Clinical Cancer Research 13 (11), 3423-3430, 2007 | 573 | 2007 |
| Regulation of tumor angiogenesis by EZH2 C Lu, HD Han, LS Mangala, R Ali-Fehmi, CS Newton, L Ozbun, ... Cancer cell 18 (2), 185-197, 2010 | 442 | 2010 |
| Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer L Yang, T Moss, LS Mangala, J Marini, H Zhao, S Wahlig, G Armaiz‐Pena, ... Molecular systems biology 10 (5), 728, 2014 | 342 | 2014 |
| Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis AK Sood, GN Armaiz-Pena, J Halder, AM Nick, RL Stone, W Hu, ... The Journal of clinical investigation 120 (5), 1515-1523, 2010 | 308 | 2010 |
| Surgical stress promotes tumor growth in ovarian carcinoma JW Lee, MMK Shahzad, YG Lin, G Armaiz-Pena, LS Mangala, HD Han, ... Clinical Cancer Research 15 (8), 2695-2702, 2009 | 260 | 2009 |
| Src activation by β-adrenoreceptors is a key switch for tumour metastasis GN Armaiz-Pena, JK Allen, A Cruz, RL Stone, AM Nick, YG Lin, LY Han, ... Nature communications 4 (1), 1403, 2013 | 225 | 2013 |
| Stress effects on FosB-and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis MMK Shahzad, JM Arevalo, GN Armaiz-Pena, C Lu, RL Stone, ... Journal of Biological Chemistry 285 (46), 35462-35470, 2010 | 218 | 2010 |
| Neuroendocrine modulation of cancer progression GN Armaiz-Pena, SK Lutgendorf, SW Cole, AK Sood Brain, behavior, and immunity 23 (1), 10-15, 2009 | 191 | 2009 |
| Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer CN Landen Jr, YG Lin, GN Armaiz Pena, PD Das, JM Arevalo, AA Kamat, ... Cancer research 67 (21), 10389-10396, 2007 | 190 | 2007 |
| Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism MB Nilsson, G Armaiz-Pena, R Takahashi, YG Lin, J Trevino, Y Li, ... Journal of Biological Chemistry 282 (41), 29919-29926, 2007 | 189 | 2007 |
| Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression R Rupaimoole, SY Wu, S Pradeep, C Ivan, CV Pecot, KM Gharpure, ... Nature communications 5 (1), 5202, 2014 | 181 | 2014 |
| Therapeutic targeting of ATP7B in ovarian carcinoma LS Mangala, V Zuzel, R Schmandt, ES Leshane, JB Halder, ... Clinical cancer research 15 (11), 3770-3780, 2009 | 171 | 2009 |
| Functional significance of VEGFR‐2 on ovarian cancer cells WA Spannuth, AM Nick, NB Jennings, GN Armaiz‐Pena, LS Mangala, ... International journal of cancer 124 (5), 1045-1053, 2009 | 170 | 2009 |
| Neuroendocrine influences on cancer progression GN Armaiz-Pena, SW Cole, SK Lutgendorf, AK Sood Brain, behavior, and immunity 30, S19-S25, 2013 | 157 | 2013 |
| A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer SY Wu, R Rupaimoole, F Shen, S Pradeep, CV Pecot, C Ivan, ... Nature communications 7 (1), 11169, 2016 | 135 | 2016 |
| 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity SY Wu, X Yang, KM Gharpure, H Hatakeyama, M Egli, MH McGuire, ... Nature communications 5 (1), 3459, 2014 | 128 | 2014 |
| Dopamine blocks stress-mediated ovarian carcinoma growth M Moreno-Smith, C Lu, MMK Shahzad, GNA Pena, JK Allen, RL Stone, ... Clinical cancer research 17 (11), 3649-3659, 2011 | 128 | 2011 |
| Targeting c-MYC in platinum-resistant ovarian cancer JM Reyes-González, GN Armaiz-Peña, LS Mangala, F Valiyeva, C Ivan, ... Molecular cancer therapeutics 14 (10), 2260-2269, 2015 | 127 | 2015 |
